Mexico to conduct late-stage trials for China, U.S. COVID-19 vaccines

MEXICO CITY (Reuters) – Mexico aims to conduct late-stage clinical trials for COVID-19 vaccines in development by Johnson & Johnson and two Chinese companies within months, the foreign minister said on Tuesday, adding that the goal was to secure access to the drugs. Mexico has signed memorandums of understanding with J&J and Chinese companies CanSino Biologics Inc and Walvax Biotechnology Co Ltd, Foreign Minister Marcelo Ebrard said at news conference. Ebrard said the trials would start between September and January, depending on approval from Mexico’s food and drug agency. More than 150 vaccines are being developed and tested around the…